DICP OpenIR
Inhibition of MAPK pathway is essential for suppressing Rheb-Y35N driven tumor growth
Wang, Y.1,2; Hong, X.3,4; Wang, J.2; Yin, Y.1; Zhang, Y.5; Zhou, Y.6; Piao, H-I1,6; Liang, Z.6; Zhang, L.6; Li, G.5; Xu, G.6; Kwiatkowski, D. J.7; Liu, Y.1,6,7
Source PublicationONCOGENE
2017-02-09
ISSN0950-9232
DOI10.1038/onc.2016.246
Volume36Issue:6Pages:756-765
Indexed BySCI
SubtypeArticle
WOS HeadingsScience & Technology ; Life Sciences & Biomedicine
WOS SubjectBiochemistry & Molecular Biology ; Oncology ; Cell Biology ; Genetics & Heredity
WOS Research AreaBiochemistry & Molecular Biology ; Oncology ; Cell Biology ; Genetics & Heredity
WOS KeywordTSC2 GAP ACTIVITY ; RHEB GTPASE ; CELL-PROLIFERATION ; MAMMALIAN TARGET ; MTOR ; ACTIVATION ; KINASE ; MUTATIONS ; AMPK ; IDENTIFICATION
AbstractRheb is a Ras family GTPase, which binds to and activates mammalian target of rapamycin complex 1 (mTORC1) when GTP loaded. Recently, cancer genome sequencing efforts have identified recurrent Rheb Tyr35Asn mutations in kidney and endometrial carcinoma. Here we show that Rheb-Y35N causes not only constitutive mTORC1 activation, but sustained activation of the MEK-ERK pathway in a TSC1/TSC2/TBC1D7 protein complex and mTORC1-independent manner, contributing to intrinsic resistance to rapamycin. Rheb-Y35N transforms NIH3T3 cells, resulting in aggressive tumor formation in xenograft nude mice, which could be suppressed by combined treatment with rapamycin and an extracellular signal-regulated kinase (ERK) inhibitor. Furthermore, Rheb-Y35N inhibits AMPKa activation in response to nutrient depletion or 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), leading to attenuated phosphorylation of BRAF-S729 and retained mitogen-activated protein kinase (MAPK) activation. Finally, we demonstrate that Rheb-WT can bind AMPK to facilitate AMPK activation, whereas Rheb-Y35N competitively binds AMPK, impairing AMPK phosphorylation. In summary, our findings indicate that Rheb-Y35N is a dominantly active tumor driver that activates both mTORC1 and MAPK to promote tumor growth, suggesting a combination of mTORC1 and MAPK inhibitors may be of therapeutic value in patients whose cancers sustain this mutation.
Language英语
WOS IDWOS:000394168200003
PublisherNATURE PUBLISHING GROUP
Citation statistics
Cited Times:8[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://cas-ir.dicp.ac.cn/handle/321008/169591
Collection中国科学院大连化学物理研究所
Corresponding AuthorKwiatkowski, D. J.; Liu, Y.
Affiliation1.Chinese Acad Sci, Sci Res Ctr Translat Med, Dalian Inst Chem Phys, Dept Biotechnol, 457 Zhongshan Rd,Rm 114, Dalian 116023, Liaoning, Peoples R China
2.Dalian Univ, Sch Life Sci, Dalian, Peoples R China
3.Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing, Peoples R China
4.Peking Union Med Coll, Beijing, Peoples R China
5.Chinese Acad Sci, Dalian Inst Chem Phys, Dept Biotechnol, State Key Lab Mol React Dynam,Lab Mol Modelling &, Dalian, Peoples R China
6.Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China
7.Harvard Med Sch, Brigham & Women Hosp, Div Pulm & Crit Care Med, Boston, MA USA
Recommended Citation
GB/T 7714
Wang, Y.,Hong, X.,Wang, J.,et al. Inhibition of MAPK pathway is essential for suppressing Rheb-Y35N driven tumor growth[J]. ONCOGENE,2017,36(6):756-765.
APA Wang, Y..,Hong, X..,Wang, J..,Yin, Y..,Zhang, Y..,...&Liu, Y..(2017).Inhibition of MAPK pathway is essential for suppressing Rheb-Y35N driven tumor growth.ONCOGENE,36(6),756-765.
MLA Wang, Y.,et al."Inhibition of MAPK pathway is essential for suppressing Rheb-Y35N driven tumor growth".ONCOGENE 36.6(2017):756-765.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Wang, Y.]'s Articles
[Hong, X.]'s Articles
[Wang, J.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Wang, Y.]'s Articles
[Hong, X.]'s Articles
[Wang, J.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Wang, Y.]'s Articles
[Hong, X.]'s Articles
[Wang, J.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.